Loading…

Copy Number Variant in the Region of Adenosine Kinase (ADK) and Its Possible Contribution to Schizophrenia Susceptibility

Adenosine kinase (ADK) is supposed to be a schizophrenia susceptibility gene based on the findings that ADK is an enzyme that catalyzes transfer of the gamma-phosphate from ATP to adenosine, which interacts with dopamine and glutamate neurotransmitters. However, no reports of schizophrenia cases wit...

Full description

Saved in:
Bibliographic Details
Published in:The international journal of neuropsychopharmacology 2018-05, Vol.21 (5), p.405-409
Main Authors: Kimura, Hiroki, Kushima, Itaru, Yohimi, Akira, Aleksic, Branko, Ozaki, Norio
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c447t-6f41b895ff721eb60b5d61e1073f1818de6a272f8a439ce2406a5fdd47deed153
cites cdi_FETCH-LOGICAL-c447t-6f41b895ff721eb60b5d61e1073f1818de6a272f8a439ce2406a5fdd47deed153
container_end_page 409
container_issue 5
container_start_page 405
container_title The international journal of neuropsychopharmacology
container_volume 21
creator Kimura, Hiroki
Kushima, Itaru
Yohimi, Akira
Aleksic, Branko
Ozaki, Norio
description Adenosine kinase (ADK) is supposed to be a schizophrenia susceptibility gene based on the findings that ADK is an enzyme that catalyzes transfer of the gamma-phosphate from ATP to adenosine, which interacts with dopamine and glutamate neurotransmitters. However, no reports of schizophrenia cases with loss of function variants in the ADK region have been published. In our previous study investigating copy number variants in schizophrenia, we detected a copy number variant in the ADK region in 1 of 1699 schizophrenia patients. We validated the ADK deletion by determining the breakpoint. Then, we compared the relative expression of ADK in 32 schizophrenia patients, including a schizophrenia patient with deletion of ADK, with 29 healthy controls using lymphoblastoid cell lines. Furthermore, we evaluated the clinical phenotypes of the schizophrenia with ADK deletion. We validated the copy number variants with Sanger sequencing and predicted that this copy number variant results in loss of function of ADK. Furthermore, expression analysis of mRNA from peripheral blood in this schizophrenia patient with the ADK deletion showed an extremely low level of ADK. Here we describe a case report of a patient with ADK deletion with phenotypes (schizophrenia, parkinsonism, epilepsy) that are predicted when ADK function is disrupted. Considering that the patient had a low ADK mRNA level and showed a phenotype that may be related to ADK deficiency, the copy number variants in the region of ADK may be strongly related to the phenotypes described here, such as schizophrenia, Parkinsonism, and epilepsy.
doi_str_mv 10.1093/ijnp/pyx103
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5932473</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1963271116</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-6f41b895ff721eb60b5d61e1073f1818de6a272f8a439ce2406a5fdd47deed153</originalsourceid><addsrcrecordid>eNpVUU1v1DAQtRCIlsKJO_KxCIV6bMfZXJBWy1fVChAFrpYTj7uusnawHUT49WTZUsFpRpo3b968R8hTYC-BteLM34TxbJx_AhP3yDFI1VY1ANz_00MFsm6OyKOcbxjjshbqITniLXAFDRyTeRPHmX6Ydh0m-s0kb0KhPtCyRfoZr30MNDq6thhi9gHphQ8mIz1dv754Tk2w9Lxk-inm7LsB6SaGknw3lf1eifSq3_pfcdwmDN7Qqyn3OBbf-cGX-TF54MyQ8cltPSFf3775snlfXX58d75ZX1a9lE2plJPQrdrauYYDdop1tVWAwBrhYAUri8rwhruVkaLtkUumTO2slY1FtFCLE_LqwDtO3Q5tj4tEM-gx-Z1Js47G6_8nwW_1dfyh61Zw2YiF4PSWIMXvE-aid355ZBhMwDhlDa0SvFkcVwv0xQHap8WShO7uDDC9D0vvw9KHsBb0s3-V3WH_piN-A1zmk-U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1963271116</pqid></control><display><type>article</type><title>Copy Number Variant in the Region of Adenosine Kinase (ADK) and Its Possible Contribution to Schizophrenia Susceptibility</title><source>PubMed (Medline)</source><source>Oxford University Press Open Access</source><creator>Kimura, Hiroki ; Kushima, Itaru ; Yohimi, Akira ; Aleksic, Branko ; Ozaki, Norio</creator><creatorcontrib>Kimura, Hiroki ; Kushima, Itaru ; Yohimi, Akira ; Aleksic, Branko ; Ozaki, Norio</creatorcontrib><description>Adenosine kinase (ADK) is supposed to be a schizophrenia susceptibility gene based on the findings that ADK is an enzyme that catalyzes transfer of the gamma-phosphate from ATP to adenosine, which interacts with dopamine and glutamate neurotransmitters. However, no reports of schizophrenia cases with loss of function variants in the ADK region have been published. In our previous study investigating copy number variants in schizophrenia, we detected a copy number variant in the ADK region in 1 of 1699 schizophrenia patients. We validated the ADK deletion by determining the breakpoint. Then, we compared the relative expression of ADK in 32 schizophrenia patients, including a schizophrenia patient with deletion of ADK, with 29 healthy controls using lymphoblastoid cell lines. Furthermore, we evaluated the clinical phenotypes of the schizophrenia with ADK deletion. We validated the copy number variants with Sanger sequencing and predicted that this copy number variant results in loss of function of ADK. Furthermore, expression analysis of mRNA from peripheral blood in this schizophrenia patient with the ADK deletion showed an extremely low level of ADK. Here we describe a case report of a patient with ADK deletion with phenotypes (schizophrenia, parkinsonism, epilepsy) that are predicted when ADK function is disrupted. Considering that the patient had a low ADK mRNA level and showed a phenotype that may be related to ADK deficiency, the copy number variants in the region of ADK may be strongly related to the phenotypes described here, such as schizophrenia, Parkinsonism, and epilepsy.</description><identifier>ISSN: 1461-1457</identifier><identifier>EISSN: 1469-5111</identifier><identifier>DOI: 10.1093/ijnp/pyx103</identifier><identifier>PMID: 29126171</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adenosine Kinase - genetics ; DNA Copy Number Variations ; Epilepsy - physiopathology ; Female ; Humans ; Middle Aged ; Parkinson Disease - physiopathology ; Phenotype ; Regular s ; RNA, Messenger ; Schizophrenia - genetics ; Schizophrenia - physiopathology</subject><ispartof>The international journal of neuropsychopharmacology, 2018-05, Vol.21 (5), p.405-409</ispartof><rights>The Author(s) 2017. Published by Oxford University Press on behalf of CINP. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-6f41b895ff721eb60b5d61e1073f1818de6a272f8a439ce2406a5fdd47deed153</citedby><cites>FETCH-LOGICAL-c447t-6f41b895ff721eb60b5d61e1073f1818de6a272f8a439ce2406a5fdd47deed153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932473/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932473/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29126171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kimura, Hiroki</creatorcontrib><creatorcontrib>Kushima, Itaru</creatorcontrib><creatorcontrib>Yohimi, Akira</creatorcontrib><creatorcontrib>Aleksic, Branko</creatorcontrib><creatorcontrib>Ozaki, Norio</creatorcontrib><title>Copy Number Variant in the Region of Adenosine Kinase (ADK) and Its Possible Contribution to Schizophrenia Susceptibility</title><title>The international journal of neuropsychopharmacology</title><addtitle>Int J Neuropsychopharmacol</addtitle><description>Adenosine kinase (ADK) is supposed to be a schizophrenia susceptibility gene based on the findings that ADK is an enzyme that catalyzes transfer of the gamma-phosphate from ATP to adenosine, which interacts with dopamine and glutamate neurotransmitters. However, no reports of schizophrenia cases with loss of function variants in the ADK region have been published. In our previous study investigating copy number variants in schizophrenia, we detected a copy number variant in the ADK region in 1 of 1699 schizophrenia patients. We validated the ADK deletion by determining the breakpoint. Then, we compared the relative expression of ADK in 32 schizophrenia patients, including a schizophrenia patient with deletion of ADK, with 29 healthy controls using lymphoblastoid cell lines. Furthermore, we evaluated the clinical phenotypes of the schizophrenia with ADK deletion. We validated the copy number variants with Sanger sequencing and predicted that this copy number variant results in loss of function of ADK. Furthermore, expression analysis of mRNA from peripheral blood in this schizophrenia patient with the ADK deletion showed an extremely low level of ADK. Here we describe a case report of a patient with ADK deletion with phenotypes (schizophrenia, parkinsonism, epilepsy) that are predicted when ADK function is disrupted. Considering that the patient had a low ADK mRNA level and showed a phenotype that may be related to ADK deficiency, the copy number variants in the region of ADK may be strongly related to the phenotypes described here, such as schizophrenia, Parkinsonism, and epilepsy.</description><subject>Adenosine Kinase - genetics</subject><subject>DNA Copy Number Variations</subject><subject>Epilepsy - physiopathology</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Parkinson Disease - physiopathology</subject><subject>Phenotype</subject><subject>Regular s</subject><subject>RNA, Messenger</subject><subject>Schizophrenia - genetics</subject><subject>Schizophrenia - physiopathology</subject><issn>1461-1457</issn><issn>1469-5111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVUU1v1DAQtRCIlsKJO_KxCIV6bMfZXJBWy1fVChAFrpYTj7uusnawHUT49WTZUsFpRpo3b968R8hTYC-BteLM34TxbJx_AhP3yDFI1VY1ANz_00MFsm6OyKOcbxjjshbqITniLXAFDRyTeRPHmX6Ydh0m-s0kb0KhPtCyRfoZr30MNDq6thhi9gHphQ8mIz1dv754Tk2w9Lxk-inm7LsB6SaGknw3lf1eifSq3_pfcdwmDN7Qqyn3OBbf-cGX-TF54MyQ8cltPSFf3775snlfXX58d75ZX1a9lE2plJPQrdrauYYDdop1tVWAwBrhYAUri8rwhruVkaLtkUumTO2slY1FtFCLE_LqwDtO3Q5tj4tEM-gx-Z1Js47G6_8nwW_1dfyh61Zw2YiF4PSWIMXvE-aid355ZBhMwDhlDa0SvFkcVwv0xQHap8WShO7uDDC9D0vvw9KHsBb0s3-V3WH_piN-A1zmk-U</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>Kimura, Hiroki</creator><creator>Kushima, Itaru</creator><creator>Yohimi, Akira</creator><creator>Aleksic, Branko</creator><creator>Ozaki, Norio</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180501</creationdate><title>Copy Number Variant in the Region of Adenosine Kinase (ADK) and Its Possible Contribution to Schizophrenia Susceptibility</title><author>Kimura, Hiroki ; Kushima, Itaru ; Yohimi, Akira ; Aleksic, Branko ; Ozaki, Norio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-6f41b895ff721eb60b5d61e1073f1818de6a272f8a439ce2406a5fdd47deed153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adenosine Kinase - genetics</topic><topic>DNA Copy Number Variations</topic><topic>Epilepsy - physiopathology</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Parkinson Disease - physiopathology</topic><topic>Phenotype</topic><topic>Regular s</topic><topic>RNA, Messenger</topic><topic>Schizophrenia - genetics</topic><topic>Schizophrenia - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimura, Hiroki</creatorcontrib><creatorcontrib>Kushima, Itaru</creatorcontrib><creatorcontrib>Yohimi, Akira</creatorcontrib><creatorcontrib>Aleksic, Branko</creatorcontrib><creatorcontrib>Ozaki, Norio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The international journal of neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimura, Hiroki</au><au>Kushima, Itaru</au><au>Yohimi, Akira</au><au>Aleksic, Branko</au><au>Ozaki, Norio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Copy Number Variant in the Region of Adenosine Kinase (ADK) and Its Possible Contribution to Schizophrenia Susceptibility</atitle><jtitle>The international journal of neuropsychopharmacology</jtitle><addtitle>Int J Neuropsychopharmacol</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>21</volume><issue>5</issue><spage>405</spage><epage>409</epage><pages>405-409</pages><issn>1461-1457</issn><eissn>1469-5111</eissn><abstract>Adenosine kinase (ADK) is supposed to be a schizophrenia susceptibility gene based on the findings that ADK is an enzyme that catalyzes transfer of the gamma-phosphate from ATP to adenosine, which interacts with dopamine and glutamate neurotransmitters. However, no reports of schizophrenia cases with loss of function variants in the ADK region have been published. In our previous study investigating copy number variants in schizophrenia, we detected a copy number variant in the ADK region in 1 of 1699 schizophrenia patients. We validated the ADK deletion by determining the breakpoint. Then, we compared the relative expression of ADK in 32 schizophrenia patients, including a schizophrenia patient with deletion of ADK, with 29 healthy controls using lymphoblastoid cell lines. Furthermore, we evaluated the clinical phenotypes of the schizophrenia with ADK deletion. We validated the copy number variants with Sanger sequencing and predicted that this copy number variant results in loss of function of ADK. Furthermore, expression analysis of mRNA from peripheral blood in this schizophrenia patient with the ADK deletion showed an extremely low level of ADK. Here we describe a case report of a patient with ADK deletion with phenotypes (schizophrenia, parkinsonism, epilepsy) that are predicted when ADK function is disrupted. Considering that the patient had a low ADK mRNA level and showed a phenotype that may be related to ADK deficiency, the copy number variants in the region of ADK may be strongly related to the phenotypes described here, such as schizophrenia, Parkinsonism, and epilepsy.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>29126171</pmid><doi>10.1093/ijnp/pyx103</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1461-1457
ispartof The international journal of neuropsychopharmacology, 2018-05, Vol.21 (5), p.405-409
issn 1461-1457
1469-5111
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5932473
source PubMed (Medline); Oxford University Press Open Access
subjects Adenosine Kinase - genetics
DNA Copy Number Variations
Epilepsy - physiopathology
Female
Humans
Middle Aged
Parkinson Disease - physiopathology
Phenotype
Regular s
RNA, Messenger
Schizophrenia - genetics
Schizophrenia - physiopathology
title Copy Number Variant in the Region of Adenosine Kinase (ADK) and Its Possible Contribution to Schizophrenia Susceptibility
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A09%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Copy%20Number%20Variant%20in%20the%20Region%20of%20Adenosine%20Kinase%20(ADK)%20and%20Its%20Possible%20Contribution%20to%20Schizophrenia%20Susceptibility&rft.jtitle=The%20international%20journal%20of%20neuropsychopharmacology&rft.au=Kimura,%20Hiroki&rft.date=2018-05-01&rft.volume=21&rft.issue=5&rft.spage=405&rft.epage=409&rft.pages=405-409&rft.issn=1461-1457&rft.eissn=1469-5111&rft_id=info:doi/10.1093/ijnp/pyx103&rft_dat=%3Cproquest_pubme%3E1963271116%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-6f41b895ff721eb60b5d61e1073f1818de6a272f8a439ce2406a5fdd47deed153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1963271116&rft_id=info:pmid/29126171&rfr_iscdi=true